NM_000540.3:c.2167+31C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000540.3(RYR1):​c.2167+31C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.199 in 1,603,514 control chromosomes in the GnomAD database, including 33,357 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2522 hom., cov: 31)
Exomes 𝑓: 0.20 ( 30835 hom. )

Consequence

RYR1
NM_000540.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 0.168

Publications

8 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • RYR1-related myopathy
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 19-38458323-C-G is Benign according to our data. Variant chr19-38458323-C-G is described in ClinVar as Benign. ClinVar VariationId is 133112.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.348 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR1NM_000540.3 linkc.2167+31C>G intron_variant Intron 18 of 105 ENST00000359596.8 NP_000531.2 P21817-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR1ENST00000359596.8 linkc.2167+31C>G intron_variant Intron 18 of 105 5 NM_000540.3 ENSP00000352608.2 P21817-1

Frequencies

GnomAD3 genomes
AF:
0.168
AC:
25484
AN:
151984
Hom.:
2524
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0787
Gnomad AMI
AF:
0.129
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.177
Gnomad EAS
AF:
0.363
Gnomad SAS
AF:
0.281
Gnomad FIN
AF:
0.203
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.191
Gnomad OTH
AF:
0.160
GnomAD2 exomes
AF:
0.209
AC:
51225
AN:
244530
AF XY:
0.212
show subpopulations
Gnomad AFR exome
AF:
0.0765
Gnomad AMR exome
AF:
0.199
Gnomad ASJ exome
AF:
0.182
Gnomad EAS exome
AF:
0.361
Gnomad FIN exome
AF:
0.209
Gnomad NFE exome
AF:
0.193
Gnomad OTH exome
AF:
0.195
GnomAD4 exome
AF:
0.202
AC:
292883
AN:
1451412
Hom.:
30835
Cov.:
30
AF XY:
0.203
AC XY:
146978
AN XY:
722690
show subpopulations
African (AFR)
AF:
0.0699
AC:
2328
AN:
33304
American (AMR)
AF:
0.199
AC:
8903
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.187
AC:
4875
AN:
26062
East Asian (EAS)
AF:
0.314
AC:
12465
AN:
39646
South Asian (SAS)
AF:
0.261
AC:
22474
AN:
86026
European-Finnish (FIN)
AF:
0.211
AC:
11118
AN:
52578
Middle Eastern (MID)
AF:
0.158
AC:
907
AN:
5750
European-Non Finnish (NFE)
AF:
0.198
AC:
217970
AN:
1103276
Other (OTH)
AF:
0.197
AC:
11843
AN:
60064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
11837
23674
35512
47349
59186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7840
15680
23520
31360
39200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.168
AC:
25486
AN:
152102
Hom.:
2522
Cov.:
31
AF XY:
0.172
AC XY:
12813
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.0787
AC:
3266
AN:
41516
American (AMR)
AF:
0.182
AC:
2786
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.177
AC:
615
AN:
3470
East Asian (EAS)
AF:
0.362
AC:
1861
AN:
5146
South Asian (SAS)
AF:
0.281
AC:
1354
AN:
4812
European-Finnish (FIN)
AF:
0.203
AC:
2154
AN:
10594
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.191
AC:
12956
AN:
67968
Other (OTH)
AF:
0.164
AC:
346
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1039
2078
3116
4155
5194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.179
Hom.:
459
Bravo
AF:
0.162
Asia WGS
AF:
0.348
AC:
1209
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
RYR1 database
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not specified Benign:1
Oct 18, 2013
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
12
DANN
Benign
0.74
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071086; hg19: chr19-38948963; COSMIC: COSV62104746; API